Alyssa Tapley, 16, became the first patient with an aggressive form of leukaemia to have the experimental treatment in 2022. She was considering options for palliative care, but is now healthy.
Your email address will not be published. Required fields are marked *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.
Δ